tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Retrognathia D063173 1 associated lipids
Drug-Related Side Effects and Adverse Reactions D064420 3 associated lipids
Scorpion Stings D065008 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Wingard JR et al. Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients. 1997 Bone Marrow Transplant. pmid:9232256
Yamagami S et al. Mechanism of concordant corneal xenograft rejection in mice: synergistic effects of anti-leukocyte function-associated antigen-1 monoclonal antibody and FK506. 1997 Transplantation pmid:9233699
Sawabe T et al. Sinus arrest during tacrolimus (FK506) and digitalis treatment in a bone marrow transplant recipient. 1997 Transplantation pmid:9233725
Misao T et al. Efficacy of combining donor-specific presensitization with a simultaneous single injection of tacrolimus on pulmonary allografts. 1997 J. Heart Lung Transplant. pmid:9402508
Suzuki J et al. Inhibition of accelerated coronary atherosclerosis with short-term blockade of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in a heterotopic murine model of heart transplantation. 1997 J. Heart Lung Transplant. pmid:9402514
Cohen SB et al. Autocrine and paracrine regulation of human T cell IL-10 production. 1997 J. Immunol. pmid:9190906
Zucker K et al. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings. 1997 Transpl. Immunol. pmid:9402690
Miyata Y et al. Phosphorylation of the immunosuppressant FK506-binding protein FKBP52 by casein kinase II: regulation of HSP90-binding activity of FKBP52. 1997 Proc. Natl. Acad. Sci. U.S.A. pmid:9405642
Taylor DO The use of tacrolimus and mycophenolate mofetil after cardiac transplantation. 1997 Curr. Opin. Cardiol. pmid:9192485
Harihara Y and Makuuchi M [Partial liver transplantation]. 1997 Nippon Naika Gakkai Zasshi pmid:9340350
Hayashi S et al. Adenovirus-mediated gene transfer to the xenogeneic liver in liver xenotransplantation: the transduction of complement regulatory factor genes (DAF and HRF20). 1997 Transplant. Proc. pmid:9193595
Wallemacq PE et al. IMx tacrolimus II vs IMx tacrolimus microparticle enzyme immunoassay evaluated in renal and hepatic transplant patients. 1997 Clin. Chem. pmid:9342026
Hohage H et al. Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients. 1997 Clin Transplant pmid:9193847
Gold BG et al. A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration. 1997 Exp. Neurol. pmid:9344552
Katari SR et al. Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients. 1997 Clin Transplant pmid:9193849
Ciancio G et al. Post-transplant lymphoproliferative disease in kidney transplant patients in the new immunosuppressive era. 1997 Clin Transplant pmid:9193850
Koneru B et al. Blood transfusions in liver recipients: a conundrum or a clear benefit in the cyclosporine/tacrolimus era? 1997 Transplantation pmid:9197350
Cameron AM et al. FKBP12 binds the inositol 1,4,5-trisphosphate receptor at leucine-proline (1400-1401) and anchors calcineurin to this FK506-like domain. 1997 J. Biol. Chem. pmid:9346894
Shafiee A et al. Chemical and biological characterization of two FK506 analogs produced by targeted gene disruption in Streptomyces sp. MA6548. 1997 J. Antibiot. pmid:9207912
Stegall MD et al. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus. 1997 Transplantation pmid:9422416
Uberti JP et al. Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies. 1997 Bone Marrow Transplant. pmid:9208118
Shihab FS et al. Mechanism of fibrosis in experimental tacrolimus nephrotoxicity. 1997 Transplantation pmid:9422427
Ohashi Y et al. Successful treatment of steroid-resistant severe acute GVHD with 24-h continuous infusion of FK506. 1997 Bone Marrow Transplant. pmid:9085743
Vu MD et al. Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat. 1997 Transplantation pmid:9422432
Oz HS and Hughes WT Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone. 1997 J. Infect. Dis. pmid:9086147
Wagner K et al. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression. 1997 J. Heart Lung Transplant. pmid:9087870
Yasutomi M et al. Evaluation of tetrahydropyranyladriamycin as an immunosuppressant in concordant xenotransplantation. 1997 J. Heart Lung Transplant. pmid:9087871
Kitagaki K et al. Facilitation of apoptosis by cyclosporins A and H, but not FK506 in mouse bronchial eosinophils. 1997 Eur. J. Pharmacol. pmid:9430427
Morrissey PE et al. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. 1997 Transplantation pmid:9089224
Midtvedt K et al. Successful pregnancies in a combined pancreas and renal allograft recipient and in a renal graft recipient on tacrolimus treatment. 1997 Nephrol. Dial. Transplant. pmid:9430893
Kiuchi T et al. A hepatic graft tuberculosis transmitted from a living-related donor. 1997 Transplantation pmid:9089234
Paterson DL and Singh N Interactions between tacrolimus and antimicrobial agents. 1997 Clin. Infect. Dis. pmid:9431391
Krämer BK and Schweda F Differing proteinuria control with cyclosporin and tacrolimus. 1997 Lancet pmid:9093272
Openshaw H Peripheral neuropathy after bone marrow transplantation. 1997 Biol. Blood Marrow Transplant. pmid:9360782
Kuromitsu S et al. 3-(13-Hydroxytridecyl)-1-[13-(3-pyridyl)tridecyl]pyridinium chloride (YM-53792), a novel inhibitor of NF-AT activation. 1997 Biochem. Pharmacol. pmid:9374420
Canzanello VJ et al. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). 1997 Liver Transpl Surg pmid:9377752
De Gasperi A and Rohrer RJ Scenario number two: sepsis and multiorgan failure after liver transplantation. 1997 Liver Transpl Surg pmid:9377761
Araki T et al. Effects of vinconate on age-related alterations in [3H]MK-801, [3H]glycine, sodium-dependent D-[3H]aspartate, [3H]FK-506 and [3H]PN200-110 binding in rats. 1997 Mech. Ageing Dev. pmid:9152958
Lang P and Baron C Molecular mechanisms of immunosuppressive chemical agents recently introduced in clinical transplantation protocols. 1997 Nephrol. Dial. Transplant. pmid:9351062
Banholzer R et al. Rapamycin destabilizes interleukin-3 mRNA in autocrine tumor cells by a mechanism requiring an intact 3' untranslated region. 1997 Mol. Cell. Biol. pmid:9154824
Waer M New immunosuppressive agents for organ transplantation. 1997 Acta Clin Belg pmid:9351290
Delehanty LL et al. Apoptosis in a Fas-resistant, T-cell receptor-sensitive human leukaemic T-cell clone. 1997 Immunology pmid:9155645
Sheiner PA et al. Increased risk of early rejection correlates with recovery of CD3 cell count after liver transplant in patients receiving OKT3 induction. 1997 Transplantation pmid:9355846
Newell KA et al. Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice. 1997 Transplantation pmid:9381541
Iyengar AR et al. Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus. 1997 Transplantation pmid:9158008
Karlsson H and Nässberger L FK506 suppresses the mitogen-induced increase in lymphocyte adhesiveness to endothelial cells, but does not affect endothelial cell activation in response to inflammatory stimuli. 1997 Transplantation pmid:9355847
van Hooff JP Pneumocystis carinii pneumonia after renal transplantation. 1997 Transplantation pmid:9158038
Ishida H et al. Cataract development induced by repeated oral dosing with FK506 (tacrolimus) in adult rats. 1997 Toxicology pmid:9355935
Siddiqui MA et al. Lymphomatoid papulosis and FK 506. 1997 Int. J. Dermatol. pmid:9159004
Wang JH and Kelly PT Attenuation of paired-pulse facilitation associated with synaptic potentiation mediated by postsynaptic mechanisms. 1997 J. Neurophysiol. pmid:9356420
Okudaira H et al. Control of allergic diseases by regulation of cytokine gene transcription. 1997 Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M pmid:9383912
Lee JW et al. Tacrolimus (FK506): validation of a sensitive enzyme-linked immunosorbent assay kit for and application to a clinical pharmacokinetic study. 1997 Ther Drug Monit pmid:9108651
Thyagarajan GK et al. FK506-induced fulminant leukoencephalopathy after single-lung transplantation. 1997 Ann. Thorac. Surg. pmid:9386723
McElwee KJ et al. Topical FK506: a potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model. 1997 Br. J. Dermatol. pmid:9390322
Huang J and Schreiber SL A yeast genetic system for selecting small molecule inhibitors of protein-protein interactions in nanodroplets. 1997 Proc. Natl. Acad. Sci. U.S.A. pmid:9391035
Durham HD et al. The immunosuppressant FK506 prolongs transgene expression in brain following adenovirus-mediated gene transfer. 1997 Neuroreport pmid:9243594
Hossain MA et al. Immunosuppression in auxiliary partial liver transplantation with FK506 in rats. 1997 Transplant. Proc. pmid:9414861
Tanaka K et al. Calcineurin inhibitor, FK506, prevents reduction in the binding capacity of cyclic AMP-dependent protein kinase in ischemic gerbil brain. 1997 J. Cereb. Blood Flow Metab. pmid:9143223
Yu C et al. Glucocorticoids fail to enhance the effect of FK506 and methotrexate in prevention of graft-versus-host disease after DLA-nonidentical, unrelated marrow transplantation. 1997 Bone Marrow Transplant. pmid:9244417
Weber M et al. Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy. 1997 Transplant. Proc. pmid:9414883
Galley Y et al. Jun NH2-terminal kinase is constitutively activated in T cells transformed by the intracellular parasite Theileria parva. 1997 Proc. Natl. Acad. Sci. U.S.A. pmid:9144200
Floren LC et al. Tacrolimus oral bioavailability doubles with coadministration of ketoconazole. 1997 Clin. Pharmacol. Ther. pmid:9246018
Scantlebury VP et al. Outcome of kidney transplantation in African-Americans using tacrolimus. 1997 Transplant. Proc. pmid:9414906
Soman KV et al. Template-based docking of a prolactin receptor proline-rich motif octapeptide to FKBP12: implications for cytokine receptor signaling. 1997 Protein Sci. pmid:9144770
Cao S et al. Potential effect of cyclosporin A in formation of cholesterol gallstones in pediatric liver transplant recipients. 1997 Dig. Dis. Sci. pmid:9246038
Wong PW and Pessah IN Noncoplanar PCB 95 alters microsomal calcium transport by an immunophilin FKBP12-dependent mechanism. 1997 Mol. Pharmacol. pmid:9145907
McKee M et al. Steroid withdrawal in tacrolimus (FK506)-treated pediatric liver transplant recipients. 1997 J. Pediatr. Surg. pmid:9247215
Marienfeld R et al. Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells. 1997 Eur. J. Immunol. pmid:9247567
Massicot F et al. Modulation of energy status and cytotoxicity induced by FK506 and cyclosporin A in a renal epithelial cell line. 1997 Arch. Toxicol. pmid:9248632
Newstead CG Tacrolimus in renal transplantation. 1997 Nephrol. Dial. Transplant. pmid:9249761
Neuhaus P et al. Tacrolimus-based immunosuppression after liver transplantation: a randomised study comparing dual versus triple low-dose oral regimens. 1997 Transpl. Int. pmid:9249934
Morris-Stiff G et al. Conversion from cyclosporin to tacrolimus in a patient with prolonged acute tubular necrosis. 1997 Transpl. Int. pmid:9287408
Gerlach J et al. Systemic liberation of interleukin-8 in the perioperative phase of liver transplantation. 1997 Transpl. Int. pmid:9287409
Michel MC et al. Comparison of old and new IMX assays for monitoring of tacrolimus levels. 1997 Transpl. Int. pmid:9287412
Brunet M [Tacrolimus (FK506): clinical, pharmacological and analytical aspects]. 1997 Med Clin (Barc) pmid:9289523
Yagi M et al. Effect of a glutamine-enriched diet on small bowel allograft during immunosuppressive therapy. 1997 Nutrition pmid:9290090
Kramer MR et al. Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506). 1997 Transplant. Proc. pmid:9290780
Holt DW and Johnston A Monitoring new immunosuppressive agents. Are the methods adequate? 1997 Drug Metabol Drug Interact pmid:9713574
Shapiro R et al. Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature. 1997 Transplant. Proc. pmid:9290809
Atkison P et al. Small bowel transplantation in children. 1997 Pediatr Transplant pmid:10084770
Webber SA 15 years of pediatric heart transplantation at the University of Pittsburgh: lessons learned and future prospects. 1997 Pediatr Transplant pmid:10084782
Hess DA et al. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation. 1997 J. Pharmacol. Exp. Ther. pmid:9103542
Kawamura N et al. Extremely high serum level of IgE during immunosuppressive therapy: paradoxical effect of cyclosporine A and tacrolimus. 1997 Int. Arch. Allergy Immunol. pmid:9104801
Beals CR et al. Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction. 1997 Genes Dev. pmid:9106655
Testa G and Klintmalm GB Cyclosporine and tacrolimus: the mainstay of immunosuppressive therapy for solid organ transplantation. 1997 Clin Liver Dis pmid:15562576
Alak AM et al. A highly sensitive enzyme-linked immunosorbent assay for the determination of tacrolimus in atopic dermatitis patients. 1997 Ther Drug Monit pmid:9029754
Padhi ID et al. Interaction between tacrolimus and erythromycin. 1997 Ther Drug Monit pmid:9029762
Tsuchida Y et al. Limb allografts in rats treated with anti-ICAM-1 and anti-LFA-1 monoclonal antibodies. 1997 J Reconstr Microsurg pmid:9044184
Wang W et al. c-Rel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation. 1997 Immunity pmid:9047238
Steiner JP et al. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. 1997 Proc. Natl. Acad. Sci. U.S.A. pmid:9050897
Seidel ER and Ragan VL Inhibition by rapamycin of ornithine decarboxylase and epithelial cell proliferation in intestinal IEC-6 cells in culture. 1997 Br. J. Pharmacol. pmid:9051292
Freiberg RA et al. Transcriptional control in keratinocytes and fibroblasts using synthetic ligands. 1997 J. Clin. Invest. pmid:9169490
Wang JH and Kelly PT Postsynaptic calcineurin activity downregulates synaptic transmission by weakening intracellular Ca2+ signaling mechanisms in hippocampal CA1 neurons. 1997 J. Neurosci. pmid:9169521
Dodd DA Rapid resolution of gingival hyperplasia after switching from cyclosporine A to tacrolimus. 1997 J. Heart Lung Transplant. pmid:9171281
Savoldi E et al. [Dental and oral aspects in pediatric liver transplant patients. A comparison between the effects of cyclosporine A and FK 506]. 1997 Minerva Stomatol pmid:9173223
Rezeig MA et al. Kaposi's sarcoma in liver transplant recipients on FK506: two case reports. 1997 Transplantation pmid:9175820
Aoki Y and Kao PN Cyclosporin A-sensitive calcium signaling represses NFkappaB activation in human bronchial epithelial cells and enhances NFkappaB activation in Jurkat T-cells. 1997 Biochem. Biophys. Res. Commun. pmid:9177287
Prasad NV et al. Metabolism of tacrolimus (FK 506) in rat liver microsomes. Effect of rifampin and dexamethasone. 1997 Res. Commun. Mol. Pathol. Pharmacol. pmid:9178371
Alak AM and Moy S Biological activity of tacrolimus (FK506) and its metabolites from whole blood of kidney transplant patients. 1997 Transplant. Proc. pmid:9270821
Rühlmann A and Nordheim A Effects of the immunosuppressive drugs CsA and FK506 on intracellular signalling and gene regulation. 1997 Immunobiology pmid:9442391